bi 1060469
Small moleculeexperimental
Clinical trial activity
6 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
6
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2013 (NCT01971502)
Timeline
2010s
- Jan 1, 2013
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- bi 1060469
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02438696 | Phase 1 | May 1, 2015 | Boehringer Ingelheim |
| NCT02202512 | Phase 1 | Sep 1, 2014 | Boehringer Ingelheim |
| NCT02225626 | Phase 1 | Sep 1, 2014 | Boehringer Ingelheim |
| NCT02183545 | Phase 1 | Jul 1, 2014 | Boehringer Ingelheim |
| NCT02126865 | Phase 1 | May 1, 2014 | Boehringer Ingelheim |
| NCT01971502 | Phase 1 | Oct 1, 2013 | Boehringer Ingelheim |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Boehringer Ingelheim | For profit | 6 | 6 | 1 | 2013 |
1 organizations
Page 1 / 1